SAM #044242

Sole Source Radiopharmaceutical Supply for Naval Medical Centers (DHA)

This opportunity is for the supply of radiopharmaceuticals to three Naval Medical Centers under the Defense Health Agency (DHA). - The DHA intends to award a sole source, firm-fixed-price IDIQ contract to Cardinal Health 414, LLC for all required radiopharmaceuticals. - The contract supports Radiology Departments at Naval Medical Center Portsmouth (VA), Naval Medical Center Camp Lejeune (NC), and Naval Hospital Jacksonville (FL). - Estimated contract value is $4,337,998.85, with a base year and four option years (totaling five years). - The period of performance is October 1, 2026, through September 30, 2031, with annual ordering periods and a 15-day start-up period. - The requirement includes a wide range of unit dose radiopharmaceuticals (e.g., Tc-99m Medronate, F-18 FDG, I-123 NaI, Ga-68 Gozetotide, Cu-64 Dotatate, and others), with specified maximum annual quantities for each product. - Deliveries are required Monday through Friday, with provisions for emergent orders, after-hours delivery, and strict regulatory compliance. - Interested parties must submit detailed capability statements demonstrating their ability to meet all technical, management, and cost requirements. - Cardinal Health 414, LLC is identified as the only source capable of meeting all requirements, but the government will consider capability statements from other vendors. - No specific part numbers are listed; all requirements and quantities are detailed in the attached draft Statement of Work.

Description

The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price indefinite delivery indefinite quantity to Cardinal Health 414, LLC for radiopharmaceuticals supplies. This purchase will be made utilizing Simplified Acquisition Procedures in accordance with Federal Regulation (FAR) Part 13.500 for supplies in amounts greater than the simplified acquisition threshold but not exceeding $9M. The contract will consist of an ordering base year and four option years; the period of performance for the base year is 01 October 2026 – 30 September 2027. Cardinal Health 414, LLC is the only source available to provide all required radiopharmaceuticals for the Radiology Departments at Naval Medical Center Portsmouth, Naval Medical Center Camp Lejeune, and Naval Hospital Jacksonville, Fl. The total estimated value is $4,337.998.85. This notice of intent is not a request for competitive proposals, and no solicitation document exists for the requirement. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of the three Radiology Departments within the Medical Treatment Facilities. Sources interested in responding to this notice are required to submit a capability statement that includes management information, technical data, and cost information in sufficient detail to demonstrate their capability of meeting all the requirements listed within the statement of work. The determination not to compete this proposed contract action is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. Information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. Capability statements to this Notice of Intent should be directed to Contracting Officer, Carol Uebelacker at carol.e.uebelacker.civ@health.mil. Please indicate in the subject of your email: Notice of Intent Submission 044242 - Radiopharmaceuticals.

View original listing